Pacira BioSciences, Inc.
PCRXPacira BioSciences is a biopharmaceutical company focused on the development and commercialization of innovative, non-opioid pain therapies.
Earnings
Next report
Nov 5, 2026 (in 2 months)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Pacira BioSciences is a biopharmaceutical company focused on the development and commercialization of innovative, non-opioid pain therapies. The company's core value proposition centers on transforming postsurgical and musculoskeletal pain management through long-acting treatments that reduce reliance on opioids. Its portfolio includes proprietary drug delivery technologies and medical devices designed to improve patient outcomes and facilitate the migration of surgeries to outpatient settings.
A leading provider of non-opioid pain management solutions with a dominant position in long-acting local anesthetics and a growing presence in gene therapy for osteoarthritis.
FAQ
- What is Pacira BioSciences, Inc.'s market cap?
- Pacira BioSciences, Inc. (PCRX) has a market capitalization of $993.0M and trades on NASDAQ.
- What is Pacira BioSciences, Inc.'s revenue and profitability?
- Pacira BioSciences, Inc. generated $734.9M in trailing twelve-month revenue with net income of $5.1M, representing a net margin of 0.7%. Gross margin stands at 79.3%, with free cash flow of $132.7M. The latest reported period is Q1 2026.
- Who are Pacira BioSciences, Inc.'s competitors?
- Pacira BioSciences, Inc.'s key competitors include Heron Therapeutics, Inc., Anika Therapeutics Inc, Collegium Pharmaceutical, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Pacira BioSciences, Inc. partner with?
- Pacira BioSciences, Inc.'s notable partners include Johnson & Johnson MedTech, LG Chem, Ltd., Thermo Fisher Scientific Pharma Services, and others.
- What subsidiaries does Pacira BioSciences, Inc. have?
- Pacira BioSciences, Inc.'s subsidiaries include Pacira Pharmaceuticals, Inc., MyoScience, Inc., Flexion Therapeutics, Inc., and others.
- Where is Pacira BioSciences, Inc. headquartered?
- Pacira BioSciences, Inc. is headquartered in United States of America and employs approximately 712 people. It has been publicly traded since 2011.
